Effect of Ginkgolide in Ischemic Stroke patients with large Artery Atherosclerosis: Results from a randomized trial

CONCLUSIONS: Ginkgolide, working as PAF antagonist, may reduce recurrent stroke in AIS with ICAS patients within 72 hours after onset. It might be an optional treatment in moderate-to-severe AIS patients with ICAS. (http://www.chictr.org.cn Number as ChiCTR-IPR-17012310).PMID:34676982 | DOI:10.1111/cns.13742

Source: CNS Neuroscience and Therapeutics - October 22, 2021 Category: Neuroscience Authors: Yi Dong Jingyu Zhang Yanxia Wang Lihong Zhao Runhui Li Chunhua Wei Qingke Bai Lishu Wan Liping Sun Shejun Feng Mingyao You Chun Wang Hongtian Zhang Qing He Ming Yu Qiang Dong GISAA committee Source Type: research